Posted in | News | Gold

Encore Renaissance Announces Progress on Bulk Exploration at Bonaparte Gold Project

Encore Renaissance Resources Corp. (TSX VENTURE:EZ)(FRANKFURT:OUH1)(PINK SHEETS:ERRCF) reports progress on the Bonaparte 10,000 ton bulk exploration program.

Development in the Bonaparte underground decline is continuing to advance in the decline heading due east to intersect the diamond drill-indicated high-grade (1.5oz/t gold or 48g/t) Eagle vein. The company has advanced 10 meters further down the decline with samples taken and sent out for assay. The company anticipates intersecting the Eagle vein within the next week. Currently there are faulting conditions in the decline that indicate the face is nearing the vein system.

The company has winterized all aspects of the project to allow continued operations throughout the coming winter months. Equipment to be operated from underground has been removed from the elements of winter and all surface generators and compressors have been winterized for continuous use. The camp trailers, first aid trailer, shop area, mine dry, mine office and storage area have been fully enclosed for winter use. These efforts have been done in anticipation of the predicted extreme weather conditions this winter.

The negotiations on the Handeni area of Tanzania gold project next to the Canaco Resources recent discovery are ongoing. Two company representatives have just returned from a two week site visit. The company will update the shareholders on the final terms of the acquisition in the near future.

Source:

Encore Renaissance Resources Corp.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.